z-logo
open-access-imgOpen Access
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
Author(s) -
Frédérique Ponchel,
Myrthe A. M. van Delft,
Xuanxiao Xie,
Agata Burska,
Laurence Duquenne,
Leendert A. Trouw,
Paul Emery
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/u891rd
Subject(s) - medicine , rheumatoid arthritis , context (archaeology) , gastroenterology , carp , arthritis , odds ratio , antibody , immunology , fish <actinopterygii> , paleontology , fishery , biology
ACR/EULAR-2010 classification criteria for rheumatoid arthritis (RA) rely heavily on the presence of anti-citrullinated peptide antibody (ACPA). The role of anti-carbamylated protein antibodies (anti-CarP) in this context is uncertain. We aimed to investigate the value of anti-CarP for RA classification in patients with early inflammatory arthritis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here